pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

Baseline characteristic of selected patients (n=57)

Characteristics mean±SD
Gender Male (%) 39 (68.4)
Female (%) 18 (31.6)

Transplantation type Living donor liver transplantation (%) 41 (71.9)
Deceased donor liver transplantation (%) 16 (28.1)

Latest Immunosuppressant Tacrolimus (%) 57 (100.0)
Mycophenolate (%) 57 (100.0)
Cyclosporine (%) 2 (3.5)
Everolimus (%) 17 (29.8)

Age (years, mean±SD) 53.7±7.2
Height (cm, mean±SD) 164.1±8.8
Weight (kg, mean±SD) 66.8±13.2
Life span after liver transplantation (month, mean±SD) 61.9±24.5
Corticosteroid period (month, mean±SD) 8.8±8.7
Corticosteroid period except rejection period (month, mean±SD) 6.9±5.1
Prednisolone conversion cumulative dosage (g, mean±SD) 5.2±3.2
Prednisolone conversion cumulative dosage except rejection (g, mean±SD) 4.3±1.2
Femur neck T-score before liver transplantation (mean±SD) -0.7±1.9
Lumbar spine T-score before liver transplantation (mean±SD) -0.4±1.4
Korean J Clin Pharm 2020;30:51-8 https://doi.org/10.24304/kjcp.2020.30.1.51
© 2020 Korean J Clin Pharm